0318 (0318) Fair Value & Analysis

Technology · Market cap HK$265M

0 0318 0318 · HK

PriceHK$0.9200

Fair ValueHK$0.4700

Upside-48.9%

Quality56/100

Evidence: Medium Range HK$0.3600 – HK$0.5900

Fair value as of: Jul 1, 2026

From 15 valuation models · updated today

Share price +31.4% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.3300 – HK$1.00 · fair‑value band HK$0.3600 – HK$0.5900 · the HK$0.9200 price screens above the HK$0.4700 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0318 (0318) currently trades at HK$0.9200, while our model-based Fair Value estimate is HK$0.4700 — implying the stock looks roughly 48.9% overvalued today. We read business quality at 56/100 (solid quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 0318 generated revenue of HK$215M at a net margin of 5.2%. Revenue declined 1.0% year over year. It earns a return on equity of 2.6%. Net debt stands at HK$19.6M. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$215M

Revenue growth (YoY) -1.0%

Net margin 5.2%

Return on equity 2.6%

Free cash flow −HK$10.9M FY2025

P/E ratio 23.0

More key figures

Operating margin 10.1%

EPS (TTM) HK$0.0400

EPS growth (YoY) +3.8%

Net debt HK$19.6M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0318 reported revenue of HK$213M in FY2025 versus HK$111M in FY2021, a compound +17.8%/yr. Reported net income was HK$10.5M in FY2025, compounding −15.1%/yr from FY2021.

Revenue +17.8%/yr

FY21 HK$111M

FY22 HK$193M

FY23 HK$202M

FY24 HK$205M

FY25 HK$213M

Net income −15.1%/yr

FY21 HK$20.2M

FY22 HK$20.0M

FY23 HK$13.5M

FY24 HK$21.1M

FY25 HK$10.5M

Is 0318 fairly valued? → Check now

Similar stocks

6 more Information Technology Services stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock	Price	Fair Value	vs Fair Value
International Business Machines Corporation IBM	$301.77	$153.91	-49%
Accenture plc ACN	$124.83	$250.14	+100%
Tata Consultancy Services Limited TCS	₹2,154	₹2,580	+20%
Infosys Limited INFY	₹1,144	₹1,305	+14%
Fujitsu Limited FJTSF	$20.73	$20.97	+1%
HCL Technologies Limited HCLTECH	₹1,131	₹2,568	+127%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0318 (0318) undervalued?

As of Jul 1, 2026, our model estimates a fair value of HK$0.4700 versus a price of HK$0.9200 — about −49% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 0318?

Our model-based fair value for 0318 is HK$0.4700 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$0.9200.

What is the quality score of 0318?

0318 has a Quality Score of 56/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0318 (0318)?

0318 reported trailing-twelve-month revenue of about HK$215M (latest available figure, as of Jul 1, 2026).

What is the net profit margin of 0318?

The net profit margin of 0318 is about 5.2%, meaning it keeps roughly 5.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.